Huo and colleagues 1 appropriately note that the low complete response rate to radiofrequency ablation (RFA) in our study contrasts markedly with much of the published literature. Their surprise regarding this finding originates from the commonly held belief that RFA effectively ablates hepatocellul
Role of locoregional therapy for hepatocellular carcinoma before liver transplantation: Answer or myth?
β Scribed by Teh-Ia Huo; Shou-Dong Lee; Jaw-Ching Wu
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 44 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20843
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatocellular carcinoma (HCC) in the setting of cirrhosis continues to increase in both the United States and abroad because of the widespread incidence of hepatitis B and C. Before the advent of transplantation, liver resection was the only method to achieve cure. However, resection is associated
Hepatocellular carcinoma (HCC) is a major health problem, being the fifth most common cancer worldwide. 1 The incidence of HCC is increasing in Europe and the United States, 2 and it is currently the leading cause of death among patients with cirrhosis. 3 The advent of surveillance programs has led